Hwi Young Kim
Visiting Scholar in the Department of Medicine, Gastroenterology
Current Appointments & Affiliations
- Visiting Scholar in the Department of Medicine, Gastroenterology, Medicine, Gastroenterology, Medicine 2022
Contact Information
- Background
-
Education, Training, & Certifications
- Ph.D., Seoul National University (South Korea) 2010
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Lee, Dong Hyeon, Sung Won Chung, Jeong-Hoon Lee, Hwi Young Kim, Goh Eun Chung, Mi-Sook Kim, Bo Ram Yang, et al. “Association of Chronic Hepatitis B Infection and Antiviral Treatment With the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study.” J Clin Oncol 40, no. 29 (October 10, 2022): 3394–3405. https://doi.org/10.1200/JCO.21.01285.Full Text Link to Item
-
Jang, Heejoon, Jun Sik Yoon, Soo Young Park, Han Ah Lee, Myoung-Jin Jang, Seung Up Kim, Dong Hyun Sinn, et al. “Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.” Clin Gastroenterol Hepatol 20, no. 6 (June 2022): 1343-1353.e16. https://doi.org/10.1016/j.cgh.2021.09.001.Full Text Link to Item
-
Kim, J. H., S. E. Kim, D. S. Song, H. Y. Kim, E. L. Yoon, T. H. Kim, Y. K. Jung, et al. “Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration.” Journal of Clinical Medicine 11, no. 9 (May 1, 2022). https://doi.org/10.3390/jcm11092463.Full Text
-
Kim, Hwi Young, Pietro Lampertico, Joon Yeul Nam, Hyung-Chul Lee, Seung Up Kim, Dong Hyun Sinn, Yeon Seok Seo, et al. “An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.” J Hepatol 76, no. 2 (February 2022): 311–18. https://doi.org/10.1016/j.jhep.2021.09.025.Full Text Link to Item
-
Chun, Ho Soo, Minjong Lee, Hye Ah Lee, Seo Yeong Oh, Hyo Jeong Baek, Jae Won Moon, Yeon Jeong Kim, et al. “Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease.” Clin Gastroenterol Hepatol, January 6, 2022. https://doi.org/10.1016/j.cgh.2021.12.043.Full Text Link to Item
-
Chun, Ho Soo, A Reum Choe, Minjong Lee, Yuri Cho, Hwi Young Kim, Kwon Yoo, and Tae Hun Kim. “Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.” Clin Mol Hepatol 27, no. 4 (October 2021): 535–52. https://doi.org/10.3350/cmh.2021.0109.Full Text Link to Item
-
Kim, Hwi Young. “Recent advances in nonalcoholic fatty liver disease metabolomics.” Clin Mol Hepatol 27, no. 4 (October 2021): 553–59. https://doi.org/10.3350/cmh.2021.0127.Full Text Link to Item
-
Chun, H. S., S. Park, M. Lee, Y. Cho, H. S. Kim, A. R. Choe, H. Y. Kim, K. Yoo, and T. H. Kim. “Association of physical activity with the risk of hepatocellular carcinoma in patients with chronic hepatitis b.” Cancers 13, no. 14 (July 2, 2021). https://doi.org/10.3390/cancers13143424.Full Text
-
Hyun, Hye Kyung, Eun Ju Cho, Soo Young Park, Young Mi Hong, Soon Sun Kim, Hwi Young Kim, Nae-Yun Heo, et al. “Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.” Dig Dis Sci 66, no. 7 (July 2021): 2427–38. https://doi.org/10.1007/s10620-020-06533-7.Full Text Link to Item
-
Lee, Jae Seung, Young Eun Chon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang Hyub Han, et al. “Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.” Yonsei Med J 62, no. 1 (January 2021): 12–20. https://doi.org/10.3349/ymj.2021.62.1.12.Full Text Link to Item
-
Ryu, Jihye, Eunmi Kim, Min-Kyung Kang, Dae-Geun Song, Eun-Ae Shin, Haesong Lee, Jae Woo Jung, et al. “Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression.” J Pathol 253, no. 1 (January 2021): 55–67. https://doi.org/10.1002/path.5548.Full Text Link to Item
-
Kim, Minseok Albert, Seung Up Kim, Dong Hyun Sinn, Jeong Won Jang, Young-Suk Lim, Sang Hoon Ahn, Jae-Jun Shim, et al. “Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study.” Gut 69, no. 12 (December 2020): 2214–22. https://doi.org/10.1136/gutjnl-2019-320015.Full Text Link to Item
-
Kim, Hwi Young, Su Jung Baik, Hye Ah Lee, Byoung Kwon Lee, Hye Sun Lee, Tae Hun Kim, and Kwon Yoo. “Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease.” Sci Rep 10, no. 1 (October 15, 2020): 17491. https://doi.org/10.1038/s41598-020-74659-9.Full Text Link to Item
-
Nam, Joon Yeul, A Reum Choe, Dong Hyun Sinn, Jeong-Hoon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, et al. “A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function.” Bmc Cancer 20, no. 1 (June 1, 2020): 504. https://doi.org/10.1186/s12885-020-06975-2.Full Text Link to Item
-
Kim, Hwi Young, and Jean-François Dufour. “Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma.” Clin Mol Hepatol 26, no. 2 (April 2020): 238–39. https://doi.org/10.3350/cmh.2020.0051.Full Text Link to Item
-
Choe, A Reum, Dong-Ryeol Ryu, Hwi Young Kim, Hye Ah Lee, Jiyoung Lim, Jin Sil Kim, Jeong Kyong Lee, Tae Hun Kim, and Kwon Yoo. “Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease.” Bmc Nephrol 21, no. 1 (February 17, 2020): 50. https://doi.org/10.1186/s12882-020-01718-8.Full Text Link to Item
-
Yoo, J. J., Y. S. Seo, Y. S. Kim, S. W. Jeong, J. Y. Jang, S. J. Suh, H. J. Yim, et al. “The influence of histologic inflammation on the improvement of liver stiffness values over 1 and 3 years.” Journal of Clinical Medicine 8, no. 12 (December 1, 2019). https://doi.org/10.3390/jcm8122065.Full Text
-
Yoon, J. S., D. H. Sinn, J. H. Lee, H. Y. Kim, C. H. Lee, S. W. Kim, H. Y. Lee, et al. “Tumor marker-based definition of the transarterial chemoembolization-refractoriness in intermediate-stage hepatocellular carcinoma: A multi-cohort study.” Cancers 11, no. 11 (November 1, 2019). https://doi.org/10.3390/cancers11111721.Full Text
-
Lee, Yun Bin, Joon Yeul Nam, Jeong-Hoon Lee, Young Chang, Hyeki Cho, Young Youn Cho, Eun Ju Cho, et al. “Publisher Correction: Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality.” Sci Rep 9, no. 1 (August 16, 2019): 12146. https://doi.org/10.1038/s41598-019-48367-y.Full Text Link to Item
-
Korean Liver Cancer Association, Jeong-Hoon, and Jeong-Hoon National Cancer Center. “2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.” Gut Liver 13, no. 3 (May 15, 2019): 227–99. https://doi.org/10.5009/gnl19024.Full Text Link to Item
-
Park, Joong-Won, Yoon Jun Kim, Do Young Kim, Si-Hyun Bae, Seung Woon Paik, Youn-Jae Lee, Hwi Young Kim, et al. “Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial.” J Hepatol 70, no. 4 (April 2019): 684–91. https://doi.org/10.1016/j.jhep.2018.11.029.Full Text Link to Item
-
Kim, Hwi Young, Young Ho So, Won Kim, Dong-Won Ahn, Yong Jin Jung, Hyunsik Woo, Donghee Kim, Moon Young Kim, and Soon Koo Baik. “Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.” J Hepatol 70, no. 3 (March 2019): 412–22. https://doi.org/10.1016/j.jhep.2018.10.018.Full Text Link to Item
-
Kim, Kyung Ah, Sun Young Choi, Min Uk Kim, Seung Yon Baek, Sang Hui Park, Kwon Yoo, Tae Hun Kim, and Hwi Young Kim. “The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.” J Vasc Interv Radiol 30, no. 3 (March 2019): 358–69. https://doi.org/10.1016/j.jvir.2018.10.002.Full Text Link to Item
-
Yun, Yeojun, Han-Na Kim, Eun-Ju Lee, Seungho Ryu, Yoosoo Chang, Hocheol Shin, Hyung-Lae Kim, Tae Hun Kim, Kwon Yoo, and Hwi Young Kim. “Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects.” Plos One 14, no. 3 (2019): e0213692. https://doi.org/10.1371/journal.pone.0213692.Full Text Link to Item
-
Cho, Yuri, Youn Su Park, Hwi Young Kim, Won Kim, Heon Ju Lee, and Dong Joon Kim. “Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.” Trials 19, no. 1 (December 22, 2018): 696. https://doi.org/10.1186/s13063-018-3092-7.Full Text Link to Item
-
Kim, Hwi Young, Jeong-Ju Yoo, Sohee Oh, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Won Kim, et al. “Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study.” J Med Virol 90, no. 10 (October 2018): 1593–1603. https://doi.org/10.1002/jmv.25241.Full Text Link to Item
-
Lee, Yun Bin, Joon Yeul Nam, Jeong-Hoon Lee, Young Chang, Hyeki Cho, Young Youn Cho, Eun Ju Cho, et al. “Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality.” Sci Rep 8, no. 1 (September 12, 2018): 13651. https://doi.org/10.1038/s41598-018-31839-y.Full Text Link to Item
-
Kim, Hwi Young, Won Kim, Yong Jin Jung, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, et al. “A Model for Adaptive Decision Making of "Ablate-and-Wait" Versus Transplantation in Patients With Hepatocellular Carcinoma.” J Clin Gastroenterol 52, no. 7 (August 2018): 655–61. https://doi.org/10.1097/MCG.0000000000000981.Full Text Link to Item
-
Kim, H. Y., and J. -. H. Lee. “Editorial: frequency of surveillance and survival in hepatocellular carcinoma-authors' reply.” Aliment Pharmacol Ther 48, no. 2 (July 2018): 229–30. https://doi.org/10.1111/apt.14827.Full Text Link to Item
-
Kim, H. Y., J. Y. Nam, J. -. H. Lee, H. A. Lee, Y. Chang, H. Y. Lee, H. Cho, et al. “Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area.” Aliment Pharmacol Ther 47, no. 11 (June 2018): 1490–1501. https://doi.org/10.1111/apt.14623.Full Text Link to Item
-
Yoo, Jeong-Ju, Goh Eun Chung, Jeong-Hoon Lee, Joon Yeul Nam, Young Chang, Jeong Min Lee, Dong Ho Lee, et al. “Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.” Cancer Res Treat 50, no. 2 (April 2018): 366–73. https://doi.org/10.4143/crt.2017.126.Full Text Link to Item
-
Kim, Hwi Young, Dong Hyeon Lee, Jeong-Hoon Lee, Young Youn Cho, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, and Jung-Hwan Yoon. “Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study.” Bmc Cancer 18, no. 1 (March 20, 2018): 307. https://doi.org/10.1186/s12885-018-4211-2.Full Text Link to Item
-
Yu, Su Jong, Jee Hye Kwon, Won Kim, Jung-Hwan Yoon, Jeong Min Lee, Jae Young Lee, Eun Ju Cho, et al. “Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.” J Clin Gastroenterol 52, no. 3 (March 2018): e18–26. https://doi.org/10.1097/MCG.0000000000000841.Full Text Link to Item
-
Kim, H. Y., and J. W. Park. “Current immunotherapeutic strategies in hepatocellular carcinoma: Recent advances and future directions.” Therapeutic Advances in Gastroenterology 10, no. 10 (October 1, 2017): 805–14. https://doi.org/10.1177/1756283X17722061.Full Text
-
Chung, Goh Eun, Eun Ju Cho, Jeong-Hoon Lee, Jeong-Ju Yoo, Minjong Lee, Yuri Cho, Dong Hyeon Lee, et al. “Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients.” Clin Mol Hepatol 23, no. 1 (March 2017): 66–73. https://doi.org/10.3350/cmh.2016.0060.Full Text Link to Item
-
Choi, J. S., W. Kim, B. K. Sohn, J. Y. Lee, H. Y. Jung, S. Oh, S. K. Joo, H. Y. Kim, and Y. J. Jung. “Association of changes in mood status and psychosocial well-being with depression during interferon-based treatment for hepatitis C.” Psychiatry Investigation 14, no. 3 (January 1, 2017): 314–24. https://doi.org/10.4306/pi.2017.14.3.314.Full Text
-
Nam, Joon Yeul, Jeong-Hoon Lee, Hwi Young Kim, Jieun E. Kim, Dong Hyeon Lee, Young Chang, Hyeki Cho, et al. “Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients.” Plos One 12, no. 1 (2017): e0166188. https://doi.org/10.1371/journal.pone.0166188.Full Text Link to Item
-
Kim, Hwi Young. “Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!.” Gut Liver 10, no. 6 (November 15, 2016): 869–70. https://doi.org/10.5009/gnl16476.Full Text Link to Item
-
Lee, Jeong-Hoon, Yuri Cho, Hwi Young Kim, Eun Ju Cho, Dong Hyeon Lee, Su Jong Yu, Jae Woo Lee, et al. “Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria.” Ann Surg 263, no. 5 (May 2016): 842–50. https://doi.org/10.1097/SLA.0000000000001578.Full Text Link to Item
-
Kim, Su Hwan, Byeong Gwan Kim, Won Kim, Sohee Oh, Hwi Young Kim, Yong Jin Jung, Ji Bong Jeong, Ji Won Kim, and Kook Lae Lee. “Characterization of gastrointestinal hemorrhage and prediction of mortality in Asian patients with alcoholic hepatitis.” J Gastroenterol Hepatol 31, no. 4 (April 2016): 814–21. https://doi.org/10.1111/jgh.13220.Full Text Link to Item
-
Kim, Hwi Young, Young Chang, Jae Yong Park, Hongkeun Ahn, Hyeki Cho, Seung Jun Han, Sohee Oh, et al. “Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism.” J Gastroenterol Hepatol 31, no. 2 (February 2016): 427–33. https://doi.org/10.1111/jgh.13084.Full Text Link to Item
-
Park, Sehhoon, Hwi Young Kim, Haeryoung Kim, Jin Hyun Park, Jung Ho Kim, Ki Hwan Kim, Won Kim, In Sil Choi, Yong Jin Jung, and Jin-Soo Kim. “Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome.” Medicine (Baltimore) 95, no. 2 (January 2016): e2454. https://doi.org/10.1097/MD.0000000000002454.Full Text Link to Item
-
Yu, Su Jong, Won Kim, Donghee Kim, Jung-Hwan Yoon, Kyoungbun Lee, Jung Ho Kim, Eun Ju Cho, et al. “Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.” Medicine (Baltimore) 94, no. 48 (December 2015): e2159. https://doi.org/10.1097/MD.0000000000002159.Full Text Link to Item
-
Chung, Kwang Hyun, Won Kim, Byeong Gwan Kim, Ho-Young Lee, Eunhyo Jin, Yuri Cho, Ji Yeon Seo, et al. “Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.” Gut Liver 9, no. 5 (September 23, 2015): 657–64. https://doi.org/10.5009/gnl14188.Full Text Link to Item
-
Joo, Sae Kyung, Jung Ho Kim, Sohee Oh, Byeong Gwan Kim, Kook Lae Lee, Hwi Young Kim, Yong Jin Jung, et al. “Prospective Comparison of Noninvasive Fibrosis Assessment to Predict Advanced Fibrosis or Cirrhosis in Asian Patients With Hepatitis C.” J Clin Gastroenterol 49, no. 8 (September 2015): 697–704. https://doi.org/10.1097/MCG.0000000000000215.Full Text Link to Item
-
Kim, Hwi Young, Eun Hyo Jin, Won Kim, Jae Young Lee, Hyunsik Woo, Sohee Oh, Ji-Yeon Seo, et al. “The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients.” Medicine (Baltimore) 94, no. 24 (June 2015): e1031. https://doi.org/10.1097/MD.0000000000001031.Full Text Link to Item
-
Korean Liver Cancer Study Group (KLCSG), E. K., and E. K. National Cancer Center, Korea (NCC). “2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.” Gut Liver 9, no. 3 (May 23, 2015): 267–317. https://doi.org/10.5009/gnl14460.Full Text Link to Item
-
Lee, Jeong-Hoon, Hwi Young Kim, Yoon Jun Kim, Jung-Hwan Yoon, Jin Wook Chung, and Hyo-Suk Lee. “Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.” J Gastroenterol Hepatol 30, no. 4 (April 2015): 696–705. https://doi.org/10.1111/jgh.12788.Full Text Link to Item
-
Hwang, Sang Youn, Su Jong Yu, Jeong-Hoon Lee, Hwi Young Kim, and Yoon Jun Kim. “Reduction of oxidative stress attenuates lipoapoptosis exacerbated by hypoxia in human hepatocytes.” Int J Mol Sci 16, no. 2 (February 3, 2015): 3323–34. https://doi.org/10.3390/ijms16023323.Full Text Link to Item
-
Korean Liver Cancer Study Group (KLCSG), E. K., and E. K. National Cancer Center, Korea (NCC). “2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.” Korean J Radiol 16, no. 3 (2015): 465–522. https://doi.org/10.3348/kjr.2015.16.3.465.Full Text Link to Item
-
Lee, M., S. Oh, H. J. Lee, T. -. S. Yeum, J. -. H. Lee, S. J. Yu, H. Y. Kim, J. -. H. Yoon, H. -. S. Lee, and Y. J. Kim. “Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.” J Viral Hepat 21, no. 12 (December 2014): 873–81. https://doi.org/10.1111/jvh.12217.Full Text Link to Item
-
Kim, Hwi Young, and Won Kim. “Chemotherapy-related reactivation of hepatitis B infection: updates in 2013.” World J Gastroenterol 20, no. 40 (October 28, 2014): 14581–88. https://doi.org/10.3748/wjg.v20.i40.14581.Full Text Link to Item
-
Kim, H. Y., and J. W. Park. “Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: Past, present, and future.” Liver Cancer 3, no. 1 (April 18, 2014): 9–17. https://doi.org/10.1159/000343854.Full Text
-
Kim, Hwi Young, Jung-Hwan Yoon, Hyo-Suk Lee, Jae Youn Cheong, Sung Won Cho, Hyoung Doo Shin, and Yoon Jun Kim. “MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B.” J Med Virol 86, no. 3 (March 2014): 446–53. https://doi.org/10.1002/jmv.23848.Full Text Link to Item
-
Lee, Minjong, Won Kim, Yunhee Choi, Sunhee Kim, Donghee Kim, Su Jong Yu, Jeong-Hoon Lee, et al. “Spontaneous evolution in bilirubin levels predicts liver-related mortality in patients with alcoholic hepatitis.” Plos One 9, no. 7 (2014): e100870. https://doi.org/10.1371/journal.pone.0100870.Full Text Link to Item
-
Kim, Hwi Young, Joong-Won Park, Jungnam Joo, Hyoseok Kim, Sang Myung Woo, Woo Jin Lee, and Chang-Min Kim. “Worse outcome of sorafenib therapy associated with ascites and Child-Pugh score in advanced hepatocellular carcinoma.” J Gastroenterol Hepatol 28, no. 11 (November 2013): 1756–61. https://doi.org/10.1111/jgh.12310.Full Text Link to Item
-
Kim, Yoon Jun, Hwi Young Kim, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Hyo-Suk Lee, Chung Yong Kim, et al. “A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.” Hum Mol Genet 22, no. 20 (October 15, 2013): 4233–38. https://doi.org/10.1093/hmg/ddt266.Full Text Link to Item
-
Seo, Ji Yeon, Won Kim, Jee Hye Kwon, Eun Hyo Jin, Su Jong Yu, Hwi Young Kim, Yong Jin Jung, et al. “Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.” Liver Int 33, no. 6 (July 2013): 884–93. https://doi.org/10.1111/liv.12132.Full Text Link to Item
-
Jun, Dae Won, Byung Ik Kim, Yong Kyun Cho, Hong Ju Kim, Young Oh Kwon, Soo Young Park, Sang Young Han, et al. “Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.” Clin Mol Hepatol 19, no. 2 (June 2013): 165–72. https://doi.org/10.3350/cmh.2013.19.2.165.Full Text Link to Item
-
Kim, Ji Won, Ji Bong Jeong, Kook Lae Lee, Byeong Gwan Kim, Yong Jin Jung, Won Kim, Hwi Young Kim, Dong Won Ahn, Seong Joon Koh, and Jae Kyung Lee. “Comparison of clinical outcomes between endoscopic and radiologic placement of self-expandable metal stent in patients with malignant colorectal obstruction.” Korean J Gastroenterol 61, no. 1 (January 25, 2013): 22–29.Link to Item
-
Kim, H. S., H. Y. Kim, C. Y. Park, J. M. Lee, J. K. Lee, C. H. Cho, S. M. Kim, and J. W. Kim. “Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: a multi-center study.” Eur J Surg Oncol 38, no. 3 (March 2012): 230–37. https://doi.org/10.1016/j.ejso.2011.12.023.Full Text Link to Item
-
Kim, H. Y., J. W. Park, J. Joo, S. J. Jung, S. An, S. M. Woo, H. B. Kim, Y. H. Koh, W. J. Lee, and C. M. Kim. “Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma.” Journal of Gastroenterology and Hepatology (Australia) 27, no. 6 (January 1, 2012): 1051–56. https://doi.org/10.1111/j.1440-1746.2011.06963.x.Full Text
-
Kim, Hwi Young, Hee-Dae Kwon, Tae Soo Jang, Jisun Lim, and Hyo-Suk Lee. “Mathematical modeling of triphasic viral dynamics in patients with HBeAg-positive chronic hepatitis B showing response to 24-week clevudine therapy.” Plos One 7, no. 11 (2012): e50377. https://doi.org/10.1371/journal.pone.0050377.Full Text Link to Item
-
Park, J. W., Y. H. Koh, H. B. Kim, H. Y. Kim, S. An, J. I. Choi, S. M. Woo, and B. H. Nam. “Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma.” Journal of Hepatology 56, no. 6 (January 1, 2012): 1336–42. https://doi.org/10.1016/j.jhep.2012.01.006.Full Text
-
Chung, G. E., W. Kim, K. L. Lee, S. Y. Hwang, J. H. Lee, H. Y. Kim, Y. J. Jung, et al. “Erratum to: Add-on adefovir is superior to a switch to entecavir as rescue therapy for lamivudine-resistant chronic hepatitis B (Digestive Diseases and Sciences DOI: 10.1007/s10620-010-1561-2).” Digestive Diseases and Sciences 56, no. 8 (August 1, 2011): 2509. https://doi.org/10.1007/s10620-011-1690-2.Full Text
-
Chung, Goh Eun, Won Kim, Kook Lae Lee, Sang Youn Hwang, Jeong-Hoon Lee, Hwi Young Kim, Yong Jin Jung, et al. “Add-on adefovir is superior to a switch to entecavir as rescue therapy for Lamivudine-resistant chronic hepatitis B.” Dig Dis Sci 56, no. 7 (July 2011): 2130–36. https://doi.org/10.1007/s10620-010-1561-2.Full Text Link to Item
-
Chung, Goh Eun, Jung-Hwan Yoon, Jeong-Hoon Lee, Hwi Young Kim, Sun Jung Myung, Su Jong Yu, Sung-Hee Lee, Soo-Mi Lee, Yoon Jun Kim, and Hyo-Suk Lee. “Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.” Oncol Rep 25, no. 6 (June 2011): 1739–46. https://doi.org/10.3892/or.2011.1239.Full Text Link to Item
-
Chung, Goh Eun, Jeong-Hoon Lee, Hwi Young Kim, Sang Youn Hwang, Joon Suk Kim, Jin Wook Chung, Jung-Hwan Yoon, Hyo-Suk Lee, and Yoon Jun Kim. “Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.” Radiology 258, no. 2 (February 2011): 627–34. https://doi.org/10.1148/radiol.10101058.Full Text Link to Item
-
Kim, H. Y., J. W. Park, B. H. Nam, H. K. Kim, J. I. Choi, T. H. Kim, H. B. Kim, and C. M. Kim. “Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments.” Journal of Gastroenterology and Hepatology (Australia) 26, no. 11 (January 1, 2011): 1612–18. https://doi.org/10.1111/j.1440-1746.2011.06751.x.Full Text
-
Kwak, Min-Sun, Jeong-Hoon Lee, Goh Eun Chung, Su Jong Yu, Eun Uk Jung, Bo Hyun Kim, Dae Hee Choi, et al. “Low P2/MS value is an independent risk factor for early recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.” Hepatogastroenterology 58, no. 105 (2011): 147–52.Link to Item
-
Lee, J. H., J. H. Yoon, Y. J. Lee, J. I. Yang, M. S. Kwak, E. J. Cho, E. S. Jang, et al. “Mesalamine-induced B7-H1 expression on hepatic stellate cells attenuates autoimmune liver injury.” Hepatology Research 41, no. 1 (January 1, 2011): 79–86. https://doi.org/10.1111/j.1872-034X.2010.00735.x.Full Text
-
Lee, Jeong-Hoon, Goh Eun Chung, Su Jong Yu, Sang Youn Hwang, Joon Suk Kim, Hwi Young Kim, Jung-Hwan Yoon, et al. “Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.” J Clin Gastroenterol 45, no. 1 (January 2011): 69–75. https://doi.org/10.1097/MCG.0b013e3181ce5dfa.Full Text Link to Item
-
Lee, Jeong-Hoon, Jung-Hwan Yoon, Su Jong Yu, Goh Eun Chung, Eun Uk Jung, Hwi Young Kim, Bo Hyun Kim, et al. “Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells.” Cancer Lett 295, no. 2 (September 28, 2010): 229–35. https://doi.org/10.1016/j.canlet.2010.03.005.Full Text Link to Item
-
Kim, Y. J., H. Y. Kim, J. S. Kim, J. -. H. Lee, J. -. H. Yoon, C. Y. Kim, B. L. Park, et al. “Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.” J Viral Hepat 17, no. 7 (July 2010): 518–26. https://doi.org/10.1111/j.1365-2893.2009.01205.x.Full Text Link to Item
-
Park, Joo Kyung, Sang Hyup Lee, Sang Gyune Kim, Hwi Young Kim, Jeong Hoon Lee, Joo Hyun Shim, Joo Sung Kim, Hyun Chae Jung, and In Sung Song. “[A case of intestinal tuberculosis presenting massive hematochezia controlled by endoscopic coagulation therapy].” Korean J Gastroenterol 45, no. 1 (January 2005): 60–63.Link to Item
-
-
Conference Papers
-
Kim, Hwi Young, and Joong-Won Park. “Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stone.” In Dig Dis, 29:303–9, 2011. https://doi.org/10.1159/000327563.Full Text Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.